- Each subject must have a level of understanding sufficient to agree to all required tests and examinations and sign an informed consent document.

- Subjects must have an initial score of at least 20 on the Montgomery-Asberg Depression Rating Scale (MADRS) at screen and at baseline of study phase I.

- Current depressive episode of at least 4 weeks duration.

- Additional inclusion criteria for substudy 4 (patients with MDD):
  - Age of onset less than 40 years of age.
  - Subjects with MDD must fulfill DSM-IV criteria for Major Depression single episode or recurrent without psychotic features based on clinical assessment and confirmed by a structured diagnostic interview (SCID-P).
  - In women of childbearing age, a negative pregnancy test within 24 hours of MRI.
  - Written informed consent completed.

- Inclusion criteria for healthy control subjects (Substudy 4 only)
  - Age 18-65 years.
  - Written informed consent completed.
